Isambard-AI and Dawn AIRR supercomputers: Rapid Access route
About This Opportunity
The Rapid Access route provides access to 20,000 GPU hours on the Isambard-AI and Dawn AI Research Resource (AIRR) supercomputers for UK-registered micro, small and medium businesses. This access route supports early-stage development of artificial intelligence (AI) products prior to market launch, aimed at start-ups and SMEs to allow them to conduct research and development activities at short notice and respond rapidly to market opportunities. Eligible research and development activities include feasibility studies, industrial research, and experimental development. The GPU hours must be used within three months of project start. No funding is available to successful applicants - this application process is purely for compute resource. While particularly keen to hear from projects contributing to government's five missions (growing economy, NHS, safer streets, opportunity for all, clean energy), this route is open to any eligible business.
Who Can Apply
- Region
- United Kingdom
- Residency
- United Kingdom
- Project in
- United Kingdom
- Applicants
- organization
- Organizations
- for profit
Application Details
Stages
- 1 single_stage
Review process
Light touch review by UKRI and DSIT delivery team on weekly cadence, assessing project objectives scope, value of AIRR access, and compliance information.
Additional benefits
- equipment
Restrictions
- reporting_requirements
External Application
This opportunity requires you to apply directly on the funder's website.
Apply on External SiteKey Information
- Award Amount
- Not specified
- Application Deadline
- No deadline
Similar Opportunities
Isambard-AI and Dawn AIRR supercomputers: Gateway route
84%This access route is open to UK-based researchers from academia, industry, and other organisations. ...
Isambard-AI and Dawn AIRR supercomputers: Innovator route
80%This opportunity provides flexible computational support for AI-related research and development pro...
Metascience Research Grants Round 2
46%This funding opportunity aims to accelerate the generation of evidence on how we can improve the eff...
Gap Fund: single-step support for medical product development (Grant)
45%Apply to the MRC 'Gap Fund' for single-step support in developing a new or repurposed medicine, medi...